Analyst Ratings for Navidea Biopharmaceuticals (navb)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 5.7 / 10
Percentile Rank: 62%
Rating Score: 5.7 / 10
Percentile Rank: 62%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/22/2019 | H.C. Wainwright | Vernon Bernardino | New Coverage | Buy (N/A) |
3.00 (N/A) |
0.68 (0.04) |
-94.12% | Details |
| 7/11/2019 | Maxim Group » Updated 2/18/2020 |
Jason McCarthy | New Coverage | Buy (N/A) |
3.00 (2.00) |
0.58 (0.04) |
-93.1% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
